Literature DB >> 30768758

Two-year-supervised resistance training prevented diabetes incidence in people with prediabetes: A randomised control trial.

Xia Dai1, Lu Zhai1, Qingyun Chen1, Joshua D Miller2, Lirong Lu3, Cunyi Hsue4, Lin Liu5, Xiaodan Yuan5, Wei Wei6, Xiaojun Ma1, Zhaohui Fang7, Wenpiao Zhao1, Yuhua Liu1, Feng Huang8, Qingqing Lou5.   

Abstract

AIM: The purpose of this study is to explore the long-term effects of aerobic training (AT), resistance training (RT), and combined training (AT + RT) on the prevention of T2D incidence in patients with prediabetes.
MATERIALS AND METHODS: In this randomised controlled trial, people with prediabetes (fasting glucose ≥5.6 and <7.0 mmol/L and/or 2-h glucose ≥7.8 and <11.1 mmol/L on the 75-g oral glucose tolerance test and/or haemoglobin A1c ≥5.7% and <6.4%) were randomly assigned to the control group, AT group, RT group, or AT + RT group. Supervised exercise programmes, including AT, RT, and AT + RT, were completed for 60 minutes per day, three non-consecutive days per week for 24 months. The primary outcome was the incidence of T2D; secondary outcomes were blood glucose and lipid levels, including total cholesterol (TC) and standard 2-hour oral glucose tolerance (2hPG).
RESULTS: A total of 137 (80%) subjects with a mean age of 59 years (45 men, 92 women) entered the final analysis. After 24 months of intervention, the incidences of T2D adjusted by sex and age were significantly decreased by 74% (95% CI, 38-89), 65% (95% CI, 21-85), and 72% (95% CI, 36-87) in the AT + RT, RT, and AT groups compared with the control group (HR: AT + RT 0.26 [95% CI, 0.11-0.62], RT 0.35 [95% CI, 0.15-0.79], and AT 0.28 [95% CI, 0.13-0.64]). The cumulative T2D incidences were significantly lower in the AT + RT, RT, and AT groups than in the control group (21%, 26%, and 22% vs 69%). The blood glucose and lipid profiles improved more in the AT, RT, and AT + RT groups than in the control group.
CONCLUSION: RT and RT plus AT were as effective as isolated AT in preventing progression to T2D.
© 2019 John Wiley & Sons, Ltd.

Entities:  

Keywords:  diabetes prevention; prediabetes; resistance training

Year:  2019        PMID: 30768758     DOI: 10.1002/dmrr.3143

Source DB:  PubMed          Journal:  Diabetes Metab Res Rev        ISSN: 1520-7552            Impact factor:   4.876


  6 in total

Review 1.  Differential Effects of Amount, Intensity, and Mode of Exercise Training on Insulin Sensitivity and Glucose Homeostasis: A Narrative Review.

Authors:  Katherine A Collins; Leanna M Ross; Cris A Slentz; Kim M Huffman; William E Kraus
Journal:  Sports Med Open       Date:  2022-07-14

2.  Non-pharmacological interventions for the prevention of type 2 diabetes in low-income and middle-income countries: a systematic review of randomised controlled trials.

Authors:  Anupam Sarker; Rina Das; Saraban Ether; Md Shariful Islam; K M Saif-Ur-Rahman
Journal:  BMJ Open       Date:  2022-06-06       Impact factor: 3.006

3.  Effectiveness of Resistance Training and Associated Program Characteristics in Patients at Risk for Type 2 Diabetes: a Systematic Review and Meta-analysis.

Authors:  Raza Qadir; Nicholas F Sculthorpe; Taylor Todd; Elise C Brown
Journal:  Sports Med Open       Date:  2021-05-29

4.  β-Cell function and body mass index are predictors of exercise response in elderly patients with prediabetes.

Authors:  Yali He; Yanhong Feng; Junli Shi; Hong Tang; Linhui Chen; Qingqing Lou
Journal:  J Diabetes Investig       Date:  2022-06-20       Impact factor: 3.681

5.  Association between domain-specific physical activity and diabetes in Korean adults.

Authors:  Eun-Byeol Lee; Sunghyun Hong; Jihee Min; Dong-Hyuk Park; Wonhee Cho; Sang-Hoon Suh; Hae-Dong Lee; Han-Joo Lee; Heejin Kimm; Sun Ha Jee; Eun Seok Kang; Dong Hoon Lee; Justin Y Jeon
Journal:  Sci Rep       Date:  2021-06-22       Impact factor: 4.379

6.  The Association between Trajectories of Anthropometric Variables and Risk of Diabetes among Prediabetic Chinese.

Authors:  Fang Li; Lizhang Chen
Journal:  Nutrients       Date:  2021-12-03       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.